Please login to the form below

Not currently logged in
Email:
Password:

antibiotics

This page shows the latest antibiotics news and features for those working in and with pharma, biotech and healthcare.

Shionogi's Gram-negative antibiotic launches in the UK

Shionogi's Gram-negative antibiotic launches in the UK

Shionogi’s novel antibiotic is designed to use the bacteria’s own iron uptake system to gain entry into the cell and inhibit cell wall synthesis. ... AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a

Latest news

  • Positive COPD data for Synairgen's SNG001 supports COVID-19 programme Positive COPD data for Synairgen's SNG001 supports COVID-19 programme

    In exacerbating patients who already required treatment with oral corticosteroids and/or antibiotics, treatment with SNG001 also significantly improved lung function compared to those who didn’t receive the drug.

  • Novartis’ Sandoz division announces antibiotic manufacturing plan Novartis’ Sandoz division announces antibiotic manufacturing plan

    Antibiotic research and development has seen a renewed focus over the last few years, as antibiotic resistance rapidly becomes a significant threat to global health. ... Although the Sandoz agreement does not include the development of next-generation

  • IFPMA launches AMR Action Fund to tackle antimicrobial resistance IFPMA launches AMR Action Fund to tackle antimicrobial resistance

    The AMR Action Fund was created to bring two to four new antibiotics to patients by 2030 – treatments which are urgently needed to address the rapid rise of antibiotic resistance, which ... with new antibiotic candidates and research, but had to file

  • We've got this! We've got this!

    As if the miracle of antibiotics wasn’t enough, imagine living through a period when receptor theory displaced our old paradigms and ʹ-blockers and ACEinhibitors emerged from the labs.

  • FDA grants emergency authorisation to chloroquine for COVID-19 FDA grants emergency authorisation to chloroquine for COVID-19

    This data supports earlier preliminary results from a small study of hydroxychloroquine in combination with the antibiotic azithromycin, and as a monotherapy. ... Although the drug was effective on its own, when added to the antibiotic azithromycin,

More from news
Approximately 63 fully matching, plus 291 partially matching documents found.

Latest Intelligence

  • COVID-19 hits supply chains COVID-19 hits supply chains

    Like Eban’s, her book views generics as the central vulnerability, especially antibiotics and medicines in the Strategic National Stockpile to be used in cases of health emergencies.

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    An earlier study of 24 COVID-19 patients, also conducted by Raoult, found that within six days of taking hydroxychloroquine and the antibiotic azithromycin, the symptoms of the virus disappeared in

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    A report from the CDC says the ‘approaching’ post-antibiotic era is already here. ... travellers. MBL enzymes break down β-lactam antibiotics, including the so-called drugs of last resort, the carbapenems.

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    Simply focusing on reduction of volume of antibiotics will not be enough either. ... This pilot project is a good start in demonstrating that new antibiotics will be fairly compensated, but more efforts are needed to stabilise the antibiotic market.

  • The mission matters The mission matters

    The success of vaccines, antibiotics, HIV treatments and many other therapies is evidence of how society has benefited from the deal.

More from intelligence
Approximately 6 fully matching, plus 39 partially matching documents found.

Latest appointments

  • New faces at 90TEN, Lucid Group and Porterhouse New faces at 90TEN, Lucid Group and Porterhouse

    In that role, Cook delivered initiatives to improve national health, including promoting responsible antibiotic use, protecting against STIs and encouraging rates of childhood immunisation.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Francesco Maria Lavino joins to support commercialisation of its new antibiotic. ... He said: “Nabriva Therapeutics is poised to introduce what is potentially the first new class of antibiotics for systemic human use in nearly two decades.

  • Destiny Pharma appoints new CEO Destiny Pharma appoints new CEO

    development. He said: “The resistance to antibiotics is becoming a global issue that needs to be addressed and I believe Destiny has a significant part to play.

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    Regulatory authorities have recognised the potential that Allecra’s novel antibiotic may contribute towards solving the crisis of resistant bacterial infections, and out lead development programme has been significantly expedited. ... With these new

  • Micreos appoints chief medical officer Micreos appoints chief medical officer

    In his new role Dr Frieling will be responsible for overseeing Micreos' antibiotic alternative, Staphefekt, as it begins clinical trials.

More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest from PMHub

  • Improving patient concordance – where does industry fit in? Improving patient concordance – where does industry fit in?

    It is about how appropriate prescribing and concordant use of any medication or intervention will improve outcomes – from taking antibiotics to checking blood sugar levels.

  • The impossible launch

    th. century, those who discovered insulin, antibiotics, IVF, polio vaccine, the contraceptive pill to name a few, have made incredible positive changes to people’s lives across the planet.

  • Behavioural Science in Healthcare Behavioural Science in Healthcare

    We are bombarded with messages about health, from the global issue of antibiotic resistance to increased obesity and heart disease, every day via every conceivable channel.

  • Antibiotic resistance: The silent pandemic

    Antibiotic resistance. Antibiotics are medicines used in the treatment and prevention of bacterial infections. ... Its aim is to increase the global use of antibiotics in the Access category (narrow-spectrum, more specific antibiotic) to 60% and reduce

  • PANDAS/PANS Awareness: A parent’s story

    What happened then? Our son was prescribed a combination antibiotic. Within a week, we saw the severity of his symptoms drop by about 70% and some of his symptoms disappear altogether,

More from PMHub
Approximately 2 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics